Trial Profile

The Role of DLBS1033 in the Management of Acute Ischemic Stroke Patients: A Randomized Controlled Study

Status: Discontinued

Phase of Trial: Phase III

Latest Information Update: 06 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lumbricus rubellus (Primary) ; Citicoline; Simvastatin; Vitamin B complex
Indications Ischaemic stroke
Focus Therapeutic Use
Sponsors Dexa Medica

Most Recent Events

12 Feb 2017 Planned End Date changed from 1 Jul 2017 to 1 Apr 2017.
12 Feb 2017 Status changed from recruiting to discontinued.
03 Aug 2016 Planned number of patients changed from 116 to 104.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com